论文信息 - Plasma miR-142 predicts major adverse cardiovascular events as an intermediate biomarker of dual antiplatelet therapy - 字舞流文

Plasma miR-142 predicts major adverse cardiovascular events as an intermediate biomarker of dual antiplatelet therapy

Ya‐Ling Han | Shi-long Zhong | C. Deng | H. Lei | Chunping Deng | Hong Wu | Qian-jie Tang | Xiao-hong Li | Ji-yan Chen | Wang-sheng Sheng | Yong-heng Fu | Yu-bi Lin | Ya-ling Han | Yong-heng Fu